{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:27:12Z","timestamp":1740108432984,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00414-024-03187-2","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T17:02:37Z","timestamp":1708448557000},"page":"1583-1592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Forensic application of three interstitial pneumonia markers: search for new pneumonia markers in dead bodies"],"prefix":"10.1007","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5420-0978","authenticated-orcid":false,"given":"Keisuke","family":"Okaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kie","family":"Horioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaro","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namiko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Moue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"3187_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1183\/09059180.00009113","volume":"23","author":"KM Antoniou","year":"2014","unstructured":"Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Polettit V (2014) Interstitial lung disease. Eur Respir Rev 23:40\u201354. https:\/\/doi.org\/10.1183\/09059180.00009113","journal-title":"Eur Respir Rev"},{"issue":"1","key":"3187_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori H, Yokoyama A, Kohno N (2012) Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig 50(1):3\u201313. https:\/\/doi.org\/10.1016\/j.resinv.2012.02.001","journal-title":"Respir Investig"},{"issue":"3","key":"3187_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/oxfordjournals.jjco.a039239","volume":"18","author":"N Kohno","year":"1988","unstructured":"Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M (1988) Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18(3):203\u2013216. https:\/\/doi.org\/10.1093\/oxfordjournals.jjco.a039239","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"3187_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","volume":"148","author":"N Kohno","year":"1993","unstructured":"Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K (1993) KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 148(3):637\u2013642. https:\/\/doi.org\/10.1164\/ajrccm\/148.3.637","journal-title":"Am Rev Respir Dis"},{"key":"3187_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cca.2013.06.002","volume":"424","author":"M Shigemura","year":"2013","unstructured":"Shigemura M, Konno S, Nasuhara Y, Shijubo N, Shimizu C, Nishimura M (2013) Serum KL-6 concentrations are associated with molecular sizes and efflux behavior of KL-6\/MUC1 in healthy subjects. Clin Chim Acta 424:148\u2013152. https:\/\/doi.org\/10.1016\/j.cca.2013.06.002","journal-title":"Clin Chim Acta"},{"issue":"3","key":"3187_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","volume":"165","author":"H Ohnishi","year":"2002","unstructured":"Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Konno N (2002) Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165(3):378\u2013381. https:\/\/doi.org\/10.1164\/ajrccm.165.3.2107134","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3187_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.resinv.2018.06.001","volume":"56","author":"H Chiba","year":"2018","unstructured":"Chiba H, Otsuka M, Takahashi H (2018) Significance of molecular biomarkers in idiopathic pulmonary fibrosis: a mini review. Respir Investig 56(5):384\u2013391. https:\/\/doi.org\/10.1016\/j.resinv.2018.06.001","journal-title":"Respir Investig"},{"issue":"3","key":"3187_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.semarthrit.2020.01.006","volume":"50","author":"M Elhai","year":"2020","unstructured":"Elhai M, Avouac J, Allanore Y (2020) Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: where do we stand? Semin Arthritis Rheum 50(3):480\u2013491. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.01.006","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"3187_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/ajrccm.159.2.9806064","volume":"159","author":"C Hermans","year":"1999","unstructured":"Hermans C, Bernard A (1999) Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 159(2):646\u2013678","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3187_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1164\/ajrccm.162.1.9903014","volume":"162","author":"H Takahashi","year":"2000","unstructured":"Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, Sagawa A, Nagae H, Abe S (2000) Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 162(1):258\u2013263. https:\/\/doi.org\/10.1164\/ajrccm.162.1.9903014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3187_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1164\/ajrccm.162.3.9910080","volume":"162","author":"H Takahashi","year":"2000","unstructured":"Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S (2000) Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162(3):1109\u20131114. https:\/\/doi.org\/10.1164\/ajrccm.162.3.9910080","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3187_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/thx.36.11.801","volume":"36","author":"DH Bowden","year":"1981","unstructured":"Bowden DH (1981) Alveolar response to injury. Thorax 36(11):801\u2013804. https:\/\/doi.org\/10.1136\/thx.36.11.801","journal-title":"Thorax"},{"issue":"8","key":"3187_CR13","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.3390\/app11083482","volume":"11","author":"R Crisan-Dabija","year":"2021","unstructured":"Crisan-Dabija R, Covic A, Brinza C, Popa IV, Burlacu A (2021) Involvement of KL-6 biomarker in interstitial lung disease induced by SARS-CoV-2 infection: a systematic review. Appl Sci 11(8):3482. https:\/\/doi.org\/10.3390\/app11083482","journal-title":"Appl Sci"},{"key":"3187_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","volume":"94","author":"Wu Di","year":"2020","unstructured":"Di Wu, Tiantian Wu, Liu Q, Yang Z (2020) The SARS-CoV-2 outbreak: what we know. Int J Infect Dis 94:44\u201348. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.004","journal-title":"Int J Infect Dis"},{"key":"3187_CR15","doi-asserted-by":"publisher","first-page":"101413","DOI":"10.1016\/j.cocis.2020.101413","volume":"51","author":"A Ghati","year":"2021","unstructured":"Ghati A, Dam P, Tasdemir D, Kati A, Sellami H, Sezgin GC, Ildiz N, Franco OL, Mandal AK, Ocsoy I (2021) Exogenous pulmonary surfactant: a review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker. Curr Opin Colloid Interface Sci 51:101413. https:\/\/doi.org\/10.1016\/j.cocis.2020.101413","journal-title":"Curr Opin Colloid Interface Sci"},{"issue":"2","key":"3187_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0379-0738(99)00228-5","volume":"109","author":"K Ishida","year":"2000","unstructured":"Ishida K, Zhu B-L, Li Quan MQ, Fujita MH (2000) Pulmonary surfactant-associated protein A levels in dead cadaveric sera with reference to the cause of death. Forensic Sci Int 109(2):125\u2013133. https:\/\/doi.org\/10.1016\/S0379-0738(99)00228-5","journal-title":"Forensic Sci Int"},{"key":"3187_CR17","doi-asserted-by":"publisher","first-page":"S301","DOI":"10.1016\/j.legalmed.2009.01.011","volume":"11","author":"Li Quan","year":"2009","unstructured":"Quan Li, Zhu B-L, Ishikawa T, Michiue T, Zhao D, Yoshida C, Chen J-H, Wang Qi, Komatsu A, Azuma Y, Maeda H (2009) Postmortem serum levels of pulmonary surfactant-associated proteins A and D with regard to the cause of death in medicolegal autopsy. Leg Med 11:S301\u2013S303. https:\/\/doi.org\/10.1016\/j.legalmed.2009.01.011","journal-title":"Leg Med"},{"issue":"2","key":"3187_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/bio.2014.0072","volume":"13","author":"K Ikeda","year":"2015","unstructured":"Ikeda K, Ichihara K, Hashiguchi T, Hidaka Y, Kang Dongchon, Maekawa M, Matsumoto H, Matsushita K, Okubo S, Tsuchiya T, Furuta K, on behalf of The Committee for Standardization, The Japanese Society of Laboratory Medicine (2015) Evaluation of the short-term stability of specimens for clinical laboratory testing. Biopreserv Biobank 13(2):135\u2013143. https:\/\/doi.org\/10.1089\/bio.2014.0072","journal-title":"Biopreserv Biobank"},{"issue":"1","key":"3187_CR19","doi-asserted-by":"publisher","first-page":"veac034","DOI":"10.1093\/ve\/veac034","volume":"8","author":"H Ode","year":"2022","unstructured":"Ode H, Nakata Y, Nagashima M, Hayashi M, Yamazaki T, Asakura H, Suzuki J, Kubota M, Matsuoka K, Matsuda M, Mori M, Sugimot A, Imahashi M, Yokomaku Y, Sadamasu K, Iwatani Y (2022) Molecular epidemiological features of SARS-CoV-2 in Japan, 2020\u20131. Virus Evol 8(1):veac034. https:\/\/doi.org\/10.1093\/ve\/veac034","journal-title":"Virus Evol"},{"issue":"2","key":"3187_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jinf.2022.04.040","volume":"85","author":"Y Hirotsu","year":"2022","unstructured":"Hirotsu Y, Maejima M, Shibusawa M, Kakizawa Y, Miyashita Y, Omata M (2022) SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022. J Infect 85(2):174\u2013211. https:\/\/doi.org\/10.1016\/j.jinf.2022.04.040","journal-title":"J Infect"},{"issue":"1","key":"3187_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/ajrccm.152.1.7599839","volume":"152","author":"IR Doyle","year":"1995","unstructured":"Doyle IR, Nicholas TE, Bersten AD (1995) Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 152(1):307\u2013317. https:\/\/doi.org\/10.1164\/ajrccm.152.1.7599839","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3187_CR22","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1016\/j.cardfail.2010.07.200","volume":"16","author":"S Netsu","year":"2010","unstructured":"Netsu S, Shishido T, Arimoto T, Takahashi H, Miyashita T, Miyamoto T, Nitone J, Kubota I (2010) Serum surfactant protein D reflects pulmonary congestion in patients with chronic heart failure. J Cardiac Fail 16(9):S169. https:\/\/doi.org\/10.1016\/j.cardfail.2010.07.200","journal-title":"J Cardiac Fail"},{"issue":"1","key":"3187_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00003246-200301000-00003","volume":"31","author":"W Cheng Ivan","year":"2003","unstructured":"Cheng Ivan W, Ware Lorraine B, Greene Kelly E, Nuckton Thomas J, Eisner Mark D, Matthay Michael A (2003) Prognostic value of surfactant proteins A and D in patients with acute lung injury*. Soc Crit Care Med 31(1):20\u201327","journal-title":"Soc Crit Care Med"},{"key":"3187_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-4-431-55582-7_5","volume-title":"Idiopathic Pulmonary Fibrosis","author":"H Chiba","year":"2016","unstructured":"Chiba H, Takahashi H (2016) Specific serum markers of IPF. Idiopathic Pulmonary Fibrosis. Springer, Tokyo, pp 61\u201376. https:\/\/doi.org\/10.1007\/978-4-431-55582-7_5"},{"key":"3187_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00414-011-0614-1","volume":"126","author":"C Palmiere","year":"2012","unstructured":"Palmiere C, Mangin P (2012) Postmortem chemistry update part II. Int J Legal Med 126:199\u2013215. https:\/\/doi.org\/10.1007\/s00414-011-0614-1","journal-title":"Int J Legal Med"},{"key":"3187_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1183\/09031936.06.00013505","volume":"28","author":"J-F Cordier","year":"2006","unstructured":"Cordier J-F (2006) Cryptogenic organising pneumonia. Eur Respir J 28:422\u2013446. https:\/\/doi.org\/10.1183\/09031936.06.00013505","journal-title":"Eur Respir J"},{"issue":"4","key":"3187_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.18907\/jjsre.36.4_348","volume":"36","author":"Y Hara","year":"2014","unstructured":"Hara Y, Kano S, Fujikura Y, Kawano S, Kanzaki Y, Misawa K, Shinkai M, Kawana A (2014) Clinical significance of serum KL-6 levels in organizing pneumonia proven by lung biopsy. Japan Soc Bronchol 36(4):348\u201352. https:\/\/doi.org\/10.18907\/jjsre.36.4_348","journal-title":"Japan Soc Bronchol"},{"issue":"975","key":"3187_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1259\/bjr\/72775434","volume":"82","author":"F Okada","year":"2009","unstructured":"Okada F, Ando Y, Honda K, Tanoue S, Matsumoto S, Mori H (2009) Comparison of pulmonary CT findings and serum KL-6 levels in patients with cryptogenic organizing pneumonia. Br J Radiol 82(975):212\u2013218. https:\/\/doi.org\/10.1259\/bjr\/72775434","journal-title":"Br J Radiol"},{"issue":"1","key":"3187_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/atm.ATM_311_19","volume":"15","author":"T Yamagishi","year":"2020","unstructured":"Yamagishi T, Kodaka N, Watanabe K, Nakano C, Oshio T, Niitsuma K, Shimada N, Matsuse H (2020) A retrospective clinical research of relapsed organizing pneumonia. Ann Thorac Med 15(1):15\u201320. https:\/\/doi.org\/10.4103\/atm.ATM_311_19","journal-title":"Ann Thorac Med"},{"issue":"1","key":"3187_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/00450618.2013.784356","volume":"46","author":"AE Donaldson","year":"2014","unstructured":"Donaldson AE, Lamont IL (2014) Estimation of post-mortem interval using biochemical markers. Aust J Forensic Sci 46(1):8\u201326. https:\/\/doi.org\/10.1080\/00450618.2013.784356","journal-title":"Aust J Forensic Sci"},{"key":"3187_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12024-009-9130-8","volume":"6","author":"DM Butzbach","year":"2010","unstructured":"Butzbach DM (2010) The influence of putrefaction and sample storage on post-mortem toxicology results. Forensic Sci Med Pathol 6:35\u201345. https:\/\/doi.org\/10.1007\/s12024-009-9130-8","journal-title":"Forensic Sci Med Pathol"},{"issue":"5","key":"3187_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.legalmed.2015.03.007","volume":"17","author":"J-H Chen","year":"2015","unstructured":"Chen J-H, Inamori-Kawamoto O, Michiue T, Ikeda S, Ishikawa T, Maeda H (2015) Cardiac biomarkers in blood, and pericardial and cerebrospinal fluids of forensic autopsy cases: a reassessment with special regard to postmortem interval. Leg Med 17(5):343\u2013350. https:\/\/doi.org\/10.1016\/j.legalmed.2015.03.007","journal-title":"Leg Med"},{"issue":"5","key":"3187_CR33","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1520\/JFS13322J","volume":"37","author":"JA Lorente","year":"1992","unstructured":"Lorente JA, Lorente M, Villanueva E (1992) Postmortem stability of lung surfactant phospholipids. J Forensic Sci 37(5):1341\u20131345. https:\/\/doi.org\/10.1520\/JFS13322J","journal-title":"J Forensic Sci"}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-024-03187-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00414-024-03187-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-024-03187-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T03:49:45Z","timestamp":1718077785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00414-024-03187-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3187"],"URL":"https:\/\/doi.org\/10.1007\/s00414-024-03187-2","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"type":"print","value":"0937-9827"},{"type":"electronic","value":"1437-1596"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval of the Human Research Ethics Committee of the University of the International University of Health and Welfare, School of Medicine (ethics approval number: 19-Im-019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Because all the subjects of this study are the dead bodies, it is impossible for us to obtain the informed consent from them. However, we are making an effort to obtain the informed consent of the families and\/or other interested parties of the dead bodies through an opt-out method via leaflets and our website.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was performed with human dead bodies. This manuscript does not contain any studies with (living) human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}